Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Adaptive Biotechnologies: Q1 Earnings Snapshot AP - Tue May 5, 4:01PM CDT

Adaptive Biotechnologies: Q1 Earnings Snapshot

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results GlobeNewswire - Tue May 5, 3:05PM CDT

SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics...

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies Reports Tomorrow With MRD Segment Under Microscope Barchart - Mon May 4, 4:01PM CDT

Barchart Research What to Expect from ADPT Earnings ADPT Generated May 4, 2026 Current Price $14.50 EPS Estimate $$-0.16 Consensus Rating Strong Buy Average Move 8.43% Adaptive Biotechnologies Reports...

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 GlobeNewswire - Wed Apr 15, 3:05PM CDT

SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies: Q4 Earnings Snapshot AP - Thu Feb 5, 3:53PM CST

Adaptive Biotechnologies: Q4 Earnings Snapshot

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire - Thu Feb 5, 3:05PM CST

SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics...

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Jan 27, 3:05PM CST

SEATTLE, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 GlobeNewswire - Thu Jan 22, 3:05PM CST

SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results GlobeNewswire - Mon Jan 12, 6:30AM CST

SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 13.81 (-5.99%)
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire - Tue Dec 30, 2025

SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 13.81 (-5.99%)

Barchart Exclusives

Palantir Stock Has a ‘High-Class Problem’: Demand for Its Software Is Far Outpacing Supply Barchart - Sun May 10, 4:00PM CDT
Palantir’s greatest challenge may no longer be demand, but how quickly it can deliver AI software to customers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.